Avalo Therapeutics Inc. (AVTX)
6.69
-0.62 (-8.48%)
At close: Mar 03, 2025, 3:59 PM
6.70
0.15%
After-hours: Mar 03, 2025, 04:00 PM EST
Avalo Therapeutics Revenue
Avalo Therapeutics reported an annual revenue of $1.92M, reflecting a -89.34% growth. For the quarter ending September 30, 2024, Avalo Therapeutics generated $249K in revenue.
Revenue (ttm)
$1.92M
Revenue Growth
-89.34%
Price / Sales Ratio
1.31
Revenue / Employee
$101.26K
Employees
19
Market Cap
70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 1.92M | -89.34% |
| Dec 31, 2022 | 18.05M | +234.40% |
| Dec 31, 2021 | 5.4M | -19.42% |
| Dec 31, 2020 | 6.7M | n/a |